Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden
Abstract Background Lung cancer is the leading cause of cancer death worldwide. With the growing number of targeted therapies and the introduction of immuno-oncology (IO), personalized medicine has become standard of care in patients with metastatic disease. The development of predictive and prognos...
Enregistré dans:
Auteurs principaux: | , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ae1a0ade6c6e4ed78175927614767cf1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|